Synergistic anti-cancer effects of selinexor and bevacizumab in mouse xenograft models of glioblastoma.

被引：0
|
作者：
Henegar, Leah [1 ]
Chang, Hua [1 ]
Walker, Christopher J. [1 ]
Kashyap, Trinayan [1 ]
Maloof, Marie [1 ]
Wang, Feng [1 ]
Martyn, Kathleen [1 ]
Orr, Shira [1 ]
Tamir, Sharon [1 ]
Kauffman, Michael G. [1 ]
Shacham, Sharon [1 ]
Landesman, Yosef [1 ]
机构：
[1] Karyopharm Therapeut Inc, Newton, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6022
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft
    Cho, Jin Hyoung
    Jeon, Young-Joo
    Park, Seon-Min
    Shin, Jae-Cheon
    Lee, Tae-Hoon
    Jung, Seunggon
    Park, Hongju
    Ryu, Joohyun
    Chen, Hanyong
    Dong, Zigang
    Shim, Jung-Hyun
    Chae, Jung-Il
    BIOMATERIALS, 2015, 53 : 274 - 284
  • [42] Restoration of miR-29b exerts anti-cancer effects on glioblastoma
    Jaekyung Shin
    Hyun Geun Shim
    Taeyoung Hwang
    Hyungsin Kim
    Shin-Hyuk Kang
    Yun-Sik Dho
    Sung-Hye Park
    Sang Jeong Kim
    Chul-Kee Park
    Cancer Cell International, 17
  • [43] Anti-cancer activity of a SN-38 nanoparticle, DEP® irinotecan, in human colon cancer xenograft models
    Kelly, Brian D.
    McLeod, Victoria
    Walker, Rachael
    Schreuders, Jeannette
    Jackson, Susan
    Giannis, Michael
    Dietinger, Christine
    Xia, Shirley
    Cargill, Anne
    Seta, Aynaz
    Hufton, Richard
    Heery, Graham
    Cullinane, Carleen
    Owen, David J.
    CANCER RESEARCH, 2020, 80 (16)
  • [44] Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
    Chen, Xiangheng
    Guan, Zhonghai
    Lu, Jun
    Wang, Haohao
    Zuo, Zhongkun
    Ye, Fei
    Huang, Jiangsheng
    Teng, Lisong
    JOURNAL OF CANCER, 2018, 9 (07): : 1207 - 1217
  • [45] Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies
    Bankert, RB
    Egilmez, NK
    Hess, SD
    TRENDS IN IMMUNOLOGY, 2001, 22 (07) : 386 - 393
  • [46] Repositioning of the approved anti-cancer drugs for the treatment of glioblastoma
    Qiao, Zhiwei
    Oyama, Rieko
    Shiozawa, Kumiko
    Kondo, Tadashi
    CANCER SCIENCE, 2018, 109 : 1149 - 1149
  • [47] Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer
    Andrea M. Tomko
    Erin G. Whynot
    Denis J. Dupré
    Journal of Cannabis Research, 4
  • [48] Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer
    Tomko, Andrea M.
    Whynot, Erin G.
    Dupre, Denis J.
    JOURNAL OF CANNABIS RESEARCH, 2022, 4 (01)
  • [49] Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models
    Li, Yanyan
    Hu, Yuan
    Liu, Chuanjin
    Wang, Qingyue
    Han, Xiaoxiao
    Han, Yong
    Xie, Xue-Shun
    Chen, Xiong-Hui
    Li, Xiang
    Siegel, Eric R.
    Afrasiabi, Kambiz
    Linskey, Mark E.
    Zhou, You-Xin
    Zhou, Yi-Hong
    ONCOTARGET, 2017, 8 (63) : 106311 - 106323
  • [50] NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model
    Liu, Wang-Qing
    Lepelletier, Yves
    Montes, Matthieu
    Borriello, Lucia
    Jarray, Rafika
    Grepin, Renaud
    Leforban, Bertrand
    Loukaci, Ali
    Benhida, Rachid
    Hermine, Olivier
    Dufour, Sylvie
    Pages, Gilles
    Garbay, Christiane
    Raynaud, Francoise
    Hadj-Slimane, Reda
    Demange, Luc
    CANCER LETTERS, 2018, 414 : 88 - 98
12345